{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:47:34Z","timestamp":1761180454960,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ecl.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T03:58:47Z","timestamp":1753156727000},"page":"649-664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric Pituitary Disorders"],"prefix":"10.1016","volume":"54","author":[{"given":"Brenda","family":"Kohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ecl.2025.06.003_bib1","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/er.2009-0008","article-title":"Genetic regulation of pituitary gland development in human and mouse","volume":"30","author":"Kelberman","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2025.06.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000341733","article-title":"Pituitary gland development: an update","volume":"23","author":"Bancalari","year":"2012","journal-title":"Endocr Dev"},{"key":"10.1016\/j.ecl.2025.06.003_bib3","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"3","article-title":"Embryologic and genetic disorders of the pituitary gland","author":"Gregory","year":"2019"},{"issue":"11","key":"10.1016\/j.ecl.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.earlhumdev.2009.08.057","article-title":"Genetic forms of hypopituitarism and their manifestation in the neonatal period","volume":"85","author":"Alatzoglou","year":"2009","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ecl.2025.06.003_bib5","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"41","article-title":"Adamantinomatous craniopharyngioma: genomics, radiologic findings, clinical, and prognosis","author":"M\u00fcller","year":"2019"},{"issue":"10","key":"10.1016\/j.ecl.2025.06.003_bib6","doi-asserted-by":"crossref","first-page":"e3820","DOI":"10.1210\/clinem\/dgab397","article-title":"Childhood-onset craniopharyngioma","volume":"106","author":"Otte","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12957-024-03411-8","article-title":"Endoscopic endonasal transsphenoidal approach improves endocrine function and surgical outcome in primary craniopharyngioma resection: a systematic review and meta- analysis","volume":"22","author":"Li","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.003_bib8","doi-asserted-by":"crossref","first-page":"e1404","DOI":"10.1210\/clinem\/dgad613","article-title":"Childhood- onset craniopharyngioma- a life- long family burden","volume":"109","author":"Beckhaus","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2024.07.002","article-title":"Diagnosis and management of children and adult craniopharyngiomas: a French endocrine society\/French society for paediatric endocrinology & diabetes consensus statement","volume":"86","author":"Cuny","year":"2024","journal-title":"Ann Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib10","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41598-025-85262-1","article-title":"Treatment of patients with tumor\/treatment- related hypothalamic obesity in the first two years following surgical treatment or radiotherapy","volume":"15","author":"M\u00fcller","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13014-024-02556-w","article-title":"39543740 Proton beam therapy for craniopharyngioma: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2024","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ecl.2025.06.003_bib12","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"71","article-title":"Prolactinomas","author":"Stanley","year":"2019"},{"issue":"20","key":"10.1016\/j.ecl.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41574-023-00948-8","article-title":"Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and Adolescence. Parts 1&2","author":"Korbonits","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ecl.2025.06.003_bib14","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"89","article-title":"Cushing disease diagnosis and treatment","author":"Tatsi","year":"2019"},{"issue":"6","key":"10.1016\/j.ecl.2025.06.003_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/cen.15096","article-title":"Diagnostic and management challenges in paediatric cushing\u2019s syndrome","volume":"101","author":"Joshi","year":"2024","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.003_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/clinem\/dgaa853","article-title":"USP8 and TP53 drivers are associated with CNV in a corticotropic adenoma cohort enriched for aggressive tumors","volume":"106","author":"Uzilov","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ecl.2025.06.003_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.003_bib18","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1210\/jc.2018-02164","article-title":"Pankratz N ,Lane J et al. Large genomic aberrations in corticotropinomas are associated with greater aggressiveness","volume":"104","author":"Tatsi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.003_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s11102-022-01237-9","article-title":"Cushing\u2019s disease in children: unique features and update on genetics","volume":"25","author":"Stratakis","year":"2022","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MED.0000000000000212","article-title":"Pituitary gigantism","volume":"23","author":"Lodish","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ecl.2025.06.003_bib21","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"3","article-title":"Gigantism and acromegaly","author":"Makri","year":"2019"},{"issue":"11","key":"10.1016\/j.ecl.2025.06.003_bib22","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2025.06.003_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","article-title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","volume":"22","author":"Beckers","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.ecl.2025.06.003_bib24","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11102-010-0275-y","article-title":"Thyroid-stimulating hormone (thyrotropin)-secretion pituitary adenoma in an 8-year-old boy: case report","volume":"15","author":"Nakayama","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2025.06.003_bib26","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"3","article-title":"TSH- secreting pituitary adenomas","author":"Gerardo","year":"2019"},{"issue":"2","key":"10.1016\/j.ecl.2025.06.003_bib27","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2009-2354","article-title":"Thyrotropin-secreting pituitary adenoma in an adolescent boy: challenges in management","volume":"126","author":"Kessler","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ecl.2025.06.003_bib28","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"3","article-title":"Non- pituitary sellar masses and infiltrative disorders","author":"Mehta","year":"2019"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41390-022-02098-5","article-title":"Optic pathway glioma and endocrine disorders in patients with and without NF1","volume":"93","author":"Gil Margolis","year":"2023","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.ecl.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2352-4642(21)00088-2","article-title":"Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline","volume":"5","author":"Cerbone","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ecl.2025.06.003_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11060-023-04453-w","article-title":"Treatment outcomes for response- based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study","volume":"164","author":"Zeng","year":"2023","journal-title":"J Neuro-oncol"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2025.06.003_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000517040","article-title":"Paediatric Langerhans Cell Histiocytosis disease: long-term sequelae in the hypothalamic endocrine system","volume":"94","author":"Vaiani","year":"2021","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/clinem\/dgab672","article-title":"Hypophysitis, the growing spectrum of a rare pituitary disease","volume":"107","author":"Langlois","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1515\/jpem-2021-0674","article-title":"A 7-year old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti- rabphilin- 3A antibody positivity","volume":"35","author":"Morota","year":"2022","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2025.06.003_bib35","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae084","article-title":"Pituitary complications of checkpoint inhibitor use","volume":"165","author":"Chamorro-Pareja","year":"2024","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2025.06.003_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1078155217727142","article-title":"Immunotherapy-induced autoimmune hypophysitis","volume":"25","author":"Valecha","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.ecl.2025.06.003_bib37","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"343","article-title":"Pituitary response to traumatic brain injury","author":"Lal","year":"2019"},{"issue":"5","key":"10.1016\/j.ecl.2025.06.003_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/EJE-19-0034","article-title":"Pituitary deficiency and precocious puberty after childhood severe traumatic brain injury: a long-term follow-up prospective study","volume":"180","author":"Dassa","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"13\u201314","key":"10.1016\/j.ecl.2025.06.003_bib39","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1089\/neu.2022.0384","article-title":"Growth hormone deficiency following traumatic brain injury in pediatric and adolescent patients: presentation, treatment, and challenges of transitioning from pediatric to adult services","volume":"40","author":"Wexler","year":"2023","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.ecl.2025.06.003_bib40","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic- pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2025.06.003_bib41","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"3","article-title":"Brain Irradiation paradigms for childhood central nervous system tumors","author":"Cooper","year":"2019"},{"key":"10.1016\/j.ecl.2025.06.003_bib42","series-title":"Pituitary disorders of childhood: diagnosis and clinical management","first-page":"3","article-title":"Hypothalamic- pituitary dysfunction as a late effect of childhood cancer, brain tumors, and their treatments","author":"Chemaitilly","year":"2019"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852925000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:34:16Z","timestamp":1761147256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852925000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0889852925000593"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2025.06.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Pituitary Disorders","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}